Know Cancer

or
forgot password

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer


N/A
18 Years
N/A
Open (Enrolling)
Both
Cervical Cancer

Thank you

Trial Information

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer


Inclusion Criteria:



- Patients must have a known or suspected cervical cancer.

- Age >18 years.

- Patients must have no other active cancer at the time of diagnosis.

- Patients must have no history of a hysterectomy.

- Patients must be able to give informed consent.

- Patients must be willing to have undergone a standard-of-care biopsy of the cervical
tumor to provide tissue for the study.

- Patients must be willing to give a blood sample to provide plasma for the study.

- Patients must have completed a standard-of-care FDG-PET/CT prior to initiation of
therapy, for assessment of lymph nodes.

- Patients must be pre-treatment.

Exclusion Criteria:

- Pregnant women

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Biomarkers (genes and proteins) of lymph node involvement

Outcome Time Frame:

4 years

Safety Issue:

No

Principal Investigator

Elizabeth Kidd, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

GYNCVX0002

NCT ID:

NCT01546363

Start Date:

February 2012

Completion Date:

December 2016

Related Keywords:

  • Cervical Cancer
  • Uterine Cervical Neoplasms

Name

Location

Stanford University Cancer InstituteStanford, California  94305